| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |